Grapefruit-derived nanovectors use an activated leukocyte trafficking pathway to deliver therapeutic agents to inflammatory tumor sites

Cancer Research

Volumn 75, Issue 12, 2015, Pages 2520-2529

  Wang, Qilong ^a,b   Ren, Yi ^c   Mu, Jingyao ^b   Egilmez, Nejat K ^b   Zhuang, Xiaoyin ^b   Deng, Zhongbin ^b   Zhang, Lifeng ^b   Yan, Jun ^b   Miller, Donald ^b   Zhang, Huang Ge ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b University of Louisville School of Medicine   (United States)

^c THE AFFILIATED HUAIAN NO 1 PEOPLE S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; DEXTRAN SULFATE; GRAPEFRUIT DERIVED NANOVECTOR; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; NANOMATERIAL; UNCLASSIFIED DRUG; NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CELL HOMING; COLITIS; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; IMMUNOCOMPETENT CELL; INFLAMMATION; LEUKOCYTE MEMBRANE; LEUKOCYTE MIGRATION; MOUSE; MOUSE MODEL; NEOPLASM; NONHUMAN; PERSONALIZED MEDICINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR MODEL; ADOPTIVE TRANSFER; ANIMAL; CHEMISTRY; COLONIC NEOPLASMS; DISEASE MODEL; FEMALE; GRAPEFRUIT; HUMAN; IMMUNOLOGY; LEUKOCYTE; LYMPHOMA, T-CELL; MAMMARY NEOPLASMS, EXPERIMENTAL; NEOPLASMS; PATHOLOGY; PROCEDURES; T LYMPHOCYTE; UMBILICAL VEIN ENDOTHELIAL CELL;

ADOPTIVE TRANSFER; ANIMALS; CITRUS PARADISI; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; LEUKOCYTES; LYMPHOMA, T-CELL; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; NANOPARTICLES; NEOPLASMS; T-LYMPHOCYTES;

EID: 84929807408     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-14-3095     Document Type: Article

References (28)

1. Kugelberg E. T cell responses: kiss and run. Nat Rev Immunol 2014; 14: 134.
2. Pober JS, Sessa WC. Evolving functions of endothelial cells in inflammation. Nat Rev Immunol 2007; 7: 803-15.
3. Schall TJ, Proudfoot AE. Overcoming hurdles in developing successful drugs targeting chemokine receptors. Nat Rev Immunol 2011; 11: 355-63.
4. Mantovani A, Bonecchi R, Locati M. Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat Rev Immunol 2006; 6: 907-18.
5. Ben-Baruch A. Organ selectivity in metastasis: regulation by chemokines and their receptors. Clin Exp Metastasis 2008; 25: 345-56.
6. Godessart N. Chemokine receptors: attractive targets for drug discovery. Ann N Y Acad Sci 2005; 1051: 647-57.
7. Warnock RA, Campbell JJ, Dorf ME, Matsuzawa A, McEvoy LM, Butcher EC. The role of chemokines in the microenvironmental control of T versus B cell arrest in Peyer's patch high endothelial venules. J Exp Med 2000; 191: 77-88.
8. Weber M, Uguccioni M, Baggiolini M, Clark-Lewis I, Dahinden CA. Deletion of the NH2-terminal residue converts monocyte chemotacticprotein 1 from an activator of basophil mediator release to an eosinophil chemoattractant. J Exp Med 1996; 183: 681-5.
9. O'Hayre M, Salanga CL, Handel TM, Hamel DJ. Emerging concepts and approaches for chemokine-receptor drug discovery. Expert opin Drug Discov 2010; 5: 1109-22.
10. Parodi A, Quattrocchi N, van de Ven AL, Chiappini C, Evangelopoulos M, Martinez JO, et al. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. Nat Nanotechnol 2013; 8: 61-8.
11. Hock SC, Ying YM, Wah CL. A review of the current scientific and regulatory status of nanomedicines and the challenges ahead. PDA J Pharm Sci Technol 2011; 65: 177-95.
12. Juliano R. Nanomedicine: is the wave cresting? Nat Rev Drug Discov 2013; 12: 171-2.
13. Zhuang X, Xiang X, Grizzle W, Sun D, Zhang S, Axtell RC, et al. Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol Ther 2011; 19: 1769-79.
14. Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 2011; 29: 341-5.
15. Wang B, Zhuang X, Deng ZB, Jiang H, Mu J, Wang Q, et al. Targeted drug delivery to intestinal macrophages by bioactive nanovesicles released from grapefruit. Mol Ther 2014; 22: 522-34.
16. Ju S, Mu J, Dokland T, Zhuang X, Wang Q, Jiang H, et al. Grape exosome-like nanoparticles induce intestinal stem cells and protect mice from DSS-induced colitis. Mol Ther 2013; 21: 1345-57.
17. Mu J, Zhuang X, Wang Q, Jiang H, Deng ZB, Wang B, et al. Interspecies communication between plant and mouse gut host cells through edible plant derived exosome-like nanoparticles. Mol Nutr Food Res 2014; 58: 1561-73.
18. Wang Q, Zhuang X, Mu J, Deng ZB, Jiang H, Zhang L, et al. Delivery of therapeutic agents by nanoparticles made of grapefruit-derived lipids. Nat Commun 2013; 4: 1867.
19. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 2000; 65: 271-84.
20. Maeda H, Matsumura Y. Tumoritropic and lymphotropic principles of macromolecular drugs. Crit Rev Ther Drug Carrier Syst 1989; 6: 193-210.
21. Gerweck LE, Seetharaman K. Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. Cancer Res 1996; 56: 1194-8.
22. Chen H, Liu X, Dou Y, He B, Liu L, Wei Z, et al. A pH-responsive cyclodextrin-based hybrid nanosystem as a nonviral vector for gene delivery. Biomaterials 2013; 34: 4159-72.
23. Li P, Liu D, Miao L, Liu C, Sun X, Liu Y, et al. A pH-sensitive multifunctional gene carrier assembled via layer-by-layer technique for efficient gene delivery. Int J Nanomed 2012; 7: 925-39.
24. Mok H, Veiseh O, Fang C, Kievit FM, Wang FY, Park JO, et al. pH-Sensitive siRNA nanovector for targeted gene silencing and cytotoxic effect in cancer cells. Mol Pharm 2010; 7: 1930-9.
25. Reymond N, d'Agua BB, Ridley AJ. Crossing the endothelial barrier during metastasis. Nat Rev Cancer 2013; 13: 858-70.
26. Balkwill F. Cancer and the chemokine network. Nat Rev Cancer 2004; 4: 540-50.
27. Lombardi L, Tavano F, Morelli F, Latiano TP, Di Sebastiano P, Maiello E. Chemokine receptor CXCR4: role in gastrointestinal cancer. Crit Rev Oncol Hematol 2013; 88: 696-705.
28. Franciszkiewicz K, Boissonnas A, Boutet M, Combadiere C, Mami-Chouaib F. Role of chemokines and chemokine receptors in shaping the effector phase of the antitumor immune response. Cancer Res 2012; 72: 6325-32.